| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) EA Eisenhauer, P Therasse, J Bogaerts, LH Schwartz, D Sargent, R Ford, ... European journal of cancer 45 (2), 228-247, 2009 | 30633 | 2009 |
| Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ... The Lancet 381 (9863), 303-312, 2013 | 3329 | 2013 |
| A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer RM Goldberg, DJ Sargent, RF Morton, CS Fuchs, RK Ramanathan, ... Journal of Clinical Oncology 22 (1), 23-30, 2004 | 3027 | 2004 |
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ... New England Journal of Medicine 349 (3), 247-257, 2003 | 2779 | 2003 |
| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 2024 | 2018 |
| Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer DJ Sargent, S Marsoni, G Monges, SN Thibodeau, R Labianca, ... Journal of clinical oncology 28 (20), 3219-3226, 2010 | 1892 | 2010 |
| Guidelines 2000 for colon and rectal cancer surgery H Nelson, N Petrelli, A Carlin, J Couture, J Fleshman, J Guillem, ... Journal of the National Cancer Institute 93 (8), 583-596, 2001 | 1863 | 2001 |
| Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999 CC Compton, LP Fielding, LJ Burgart, B Conley, HS Cooper, SR Hamilton, ... Archives of pathology & laboratory medicine 124 (7), 979-994, 2000 | 1758 | 2000 |
| Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy S Kopetz, GJ Chang, MJ Overman, C Eng, DJ Sargent, DW Larson, ... Journal of clinical oncology 27 (22), 3677-3683, 2009 | 1564 | 2009 |
| Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial J Fleshman, DJ Sargent, E Green, M Anvari, SJ Stryker, RW Beart Jr, ... Annals of surgery 246 (4), 655-664, 2007 | 1488 | 2007 |
| Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment A Grothey, D Sargent, RM Goldberg, HJ Schmoll Journal of Clinical Oncology 22 (7), 1209-1214, 2004 | 1373 | 2004 |
| Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? S Gill, CL Loprinzi, DJ Sargent, SD Thomé, SR Alberts, DG Haller, ... Journal of clinical oncology 22 (10), 1797-1806, 2004 | 1368 | 2004 |
| Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial J Fleshman, M Branda, DJ Sargent, AM Boller, V George, M Abbas, ... Jama 314 (13), 1346-1355, 2015 | 1318 | 2015 |
| A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients DJ Sargent, RM Goldberg, SD Jacobson, JS Macdonald, R Labianca, ... New England Journal of Medicine 345 (15), 1091-1097, 2001 | 1208 | 2001 |
| Duration of adjuvant chemotherapy for stage III colon cancer A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ... New England Journal of Medicine 378 (13), 1177-1188, 2018 | 1053 | 2018 |
| Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial JC Weeks, H Nelson, S Gelber, D Sargent, G Schroeder, ... Jama 287 (3), 321-328, 2002 | 1018 | 2002 |
| Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors NM Lindor, LJ Burgart, O Leontovich, RM Goldberg, JM Cunningham, ... Journal of clinical oncology 20 (4), 1043-1048, 2002 | 1000 | 2002 |
| Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. X Paoletti, K Oba, T Burzykowski, S Michiels, Y Ohashi, JP Pignon, ... Jama 303 (17), 1729-1737, 2010 | 969 | 2010 |
| Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) A Grothey, MM Sugrue, DM Purdie, W Dong, D Sargent, E Hedrick, ... Journal of clinical oncology 26 (33), 5326-5334, 2008 | 928 | 2008 |
| Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials DJ Sargent, HS Wieand, DG Haller, R Gray, JK Benedetti, M Buyse, ... Journal of Clinical Oncology 23 (34), 8664-8670, 2005 | 804 | 2005 |
